Clinical Trial Update: Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a dengue vaccine in healthy children and adolescents in South America; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue
• Dengue Hemorrhagic Fever

Drugs mentioned

• CYD Dengue vaccine (dengue vaccine, live attenuated tetravalent)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Dengue, Dengue Hemorrhagic Fever | Phase 2 | Status: COMPLETED | Results posted: 2016-11-11